Decibel Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2022 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary: Decibel Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2022 to Q2 2023.
Decibel Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2023 was $2.14M, a 35.2% decline year-over-year.

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2023	$2.14M	-$1.16M	-35.2%	Jun 30, 2023	10-Q	2023-08-11
Q1 2023	$2.41M	-$1.21M	-33.4%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$2.69M			Dec 31, 2022	10-K	2023-03-14
Q3 2022	$2.99M			Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$3.3M			Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$3.62M			Mar 31, 2022	10-Q	2022-05-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.